Rahul Sarugaser's questions to Profound Medical Corp (PROF) leadership • Q2 2024
Question
Rahul Sarugaser of Raymond James questioned how the three new CPT codes could be leveraged to stack procedures and increase physician profitability, sought an update on the company's BPH strategy, and asked about the applicability of the new codes for BPH treatment. He also inquired about the internal morale at Profound.
Answer
CEO Arun Menawat provided examples of how the codes offer flexibility, such as a primary physician handling the core treatment while a resident manages setup and recovery, optimizing the lead physician's time and RVUs per hour. He explained the BPH strategy will initially target patients with large prostates (>100cc) and that the company believes the current FDA clearance and associated CPT codes will apply to BPH ablation. He concluded that the team's morale is high and focused on execution.